Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1976 2
1977 3
1978 2
1985 1
1988 1
1989 1
1993 2
1994 2
1995 2
1996 2
1998 3
1999 1
2000 1
2001 4
2002 5
2003 6
2004 14
2005 11
2006 14
2007 13
2008 7
2009 8
2010 11
2011 16
2012 8
2013 11
2014 6
2015 2
2016 5
2017 5
2018 10
2019 4
2020 4
2021 4
2022 6
2023 4
2024 7
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829. JAMA Oncol. 2022. PMID: 36048453 Free PMC article. Clinical Trial.
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, Loiseau N, Postic C, Langin D, Wahli W, Guillou H. Montagner A, et al. Among authors: cano p. Gut. 2016 Jul;65(7):1202-14. doi: 10.1136/gutjnl-2015-310798. Epub 2016 Feb 1. Gut. 2016. PMID: 26838599 Free PMC article.
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression Panel.
Ozakinci H, Alontaga AY, Cano P, Koomen JM, Perez BA, Beg AA, Chiappori AA, Haura EB, Boyle TA. Ozakinci H, et al. Among authors: cano p. JTO Clin Res Rep. 2024 Aug 28;5(11):100723. doi: 10.1016/j.jtocrr.2024.100723. eCollection 2024 Nov. JTO Clin Res Rep. 2024. PMID: 39386315 Free PMC article.
Persistence of Oropouche virus in body fluids among imported cases in France, 2024.
Gourjault C, Pezzi L, Doudier B, Minodier P, Klitting R, Cano P, Ayhan N, Touret F, Grard G, Durand GA, Driouich JS, Luciani L, Nougairède A, Lagier JC, de Lamballerie X, Cassir N. Gourjault C, et al. Among authors: cano p. Lancet Infect Dis. 2025 Feb;25(2):e64-e65. doi: 10.1016/S1473-3099(24)00815-6. Epub 2024 Dec 19. Lancet Infect Dis. 2025. PMID: 39709970 No abstract available.
Melatonin role in experimental arthritis.
Cardinali DP, García AP, Cano P, Esquifino AI. Cardinali DP, et al. Among authors: cano p. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Mar;4(1):1-10. doi: 10.2174/1568008043340071. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15032620 Review.
Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV).
Moorad R, Peng A, Landis J, Pluta LJ, Cano P, Juarez A, Dittmer DP. Moorad R, et al. Among authors: cano p. J Virol. 2025 May 20;99(5):e0195024. doi: 10.1128/jvi.01950-24. Epub 2025 Apr 16. J Virol. 2025. PMID: 40237497 Free PMC article.
Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical Care.
Alontaga AY, Cano P, Ozakinci H, Puskas JA, Stewart PA, Welsh EA, Yoder SJ, Hicks JK, Saltos AN, Bossler AD, Haura EB, Koomen JM, Boyle TA. Alontaga AY, et al. Among authors: cano p. J Mol Diagn. 2024 Aug;26(8):685-699. doi: 10.1016/j.jmoldx.2024.04.005. Epub 2024 May 21. J Mol Diagn. 2024. PMID: 38777037 Free PMC article.
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.
Abou-Alfa GK, Meyer T, Do RKG, Piha-Paul SA, Light JS, Sherrin S, Yaqubie A, O'Neill AC, Harding JJ, Al-Rajabi R, Denlinger CS, Cano P, Cornelius AS, O'Reilly EM, DiPrimeo D, Eli LD, Gordan JD, Solit DB. Abou-Alfa GK, et al. Among authors: cano p. Liver Cancer. 2024 Aug 8;14(1):58-67. doi: 10.1159/000540290. eCollection 2025 Mar. Liver Cancer. 2024. PMID: 40144471 Free PMC article.
191 results